Summit Therapeutics Inc. SEC filings SMMT
Summit Therapeutics Inc. has 564 filings in SEC EDGAR's recent list, going back to Mar 4, 2014. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B7 | Filing | Nov 4, 2026 | — |
| 424B5 | Prospectus supplement | Jul 23, 2026 | — |
| 424B5 | Prospectus supplement | Jun 10, 2026 | — |
| S-3ASR | Automatic shelf registration | Jun 9, 2026 | — |
| S-8 | Employee stock plan registration | Feb 23, 2026 | — |
| S-3ASR | Automatic shelf registration | Oct 29, 2025 | — |
| 424B5 | Prospectus supplement | Aug 11, 2025 | — |
| S-8 | Employee stock plan registration | May 19, 2025 | — |
| S-3ASR | Automatic shelf registration | Sep 19, 2024 | — |
| S-3ASR | Automatic shelf registration | Aug 6, 2024 | — |
| 424B5 | Prospectus supplement | May 13, 2024 | — |
| S-8 | Employee stock plan registration | May 1, 2024 | — |
| S-3 | Shelf registration | Feb 20, 2024 | — |
| S-3 | Shelf registration | Mar 17, 2023 | — |
| 424B4 | Prospectus | Feb 7, 2023 | — |
| S-3/A | Amendment to form s-3 | Jan 23, 2023 | — |
| S-3 | Shelf registration | Dec 21, 2022 | — |
| 424B4 | Prospectus | Jul 18, 2022 | — |
| S-8 | Employee stock plan registration | Apr 6, 2022 | — |
| 424B4 | Prospectus | Apr 21, 2021 | — |
| 424B4 | Prospectus | Jan 20, 2021 | — |
| S-3 | Shelf registration | Jan 8, 2021 | — |
| S-3 | Shelf registration | Oct 5, 2020 | — |
| S-8 | Employee stock plan registration | Oct 5, 2020 | — |
| S-8 POS | Filing | Oct 5, 2020 | — |
| S-8 | Employee stock plan registration | May 21, 2020 | — |
| 424B3 | Prospectus | Jun 21, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 12, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | May 15, 2018 | — |
| 424B5 | Prospectus supplement | Sep 14, 2017 | — |
| 424B5 | Prospectus supplement | Sep 13, 2017 | — |
| F-3/A | Filing | May 26, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | May 12, 2016 | — |
| 424B4 | Prospectus | Mar 5, 2015 | — |
| F-1/A | Filing | Feb 27, 2015 | — |
| F-6 | Form f-6 | Feb 20, 2015 | — |
| F-1/A | Form f-1 amendment no.1 | Feb 20, 2015 | — |
| F-1 | Registration statement (foreign issuer) | Jan 30, 2015 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SMMT (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Miami, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1599298
- Former names
- Summit Therapeutics plc (until Sep 17, 2020); Summit Corp plc (until Jan 30, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.